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Summary. A simple and sensitive flow cytometric method 
is presented for the quantitation of erythrocyte subpopu­
lations. Cells were indirectly labelled using human antisera 
(mostly crude) and fluorescein isothiocyanate (FITC)- 
conjugated anti-human IgG Fai,. The method was evaluated 
by analysing artificial mixtures of blood group antigens A, B, 
D, E, c, K and Fya. Intra-assay coefficients of variation were 
found to be 7-2% for 1% D-positive mixtures and 2*2% for
variation were 9-5% and Cr()% respectively. The sensitivity of 
the method was found to be 031% . The method has shown 
to be suitable for the routine follow-up of patients after 
allogeneic bone marrow transplantation (BMT).
Keywords: flow cytometry, bone marrow transplantation, 
red blood cells.
The quantitation of autologous and donor erythrocyte 
subpopulations in patients after allogeneic BMT was
i minor
determined by following the repopulation of red 
indentiiication of relapses at an early stage, and the detection 
of long-term chimaerism. We have previously described a 
method to detect erythrocyte chimaerism using fluorescent 
microspheres (de Man et al, 1988) with a sensitivity of 0-01% 
positive cells.
Flow cytometry (FC) is an analysis method increasingly 
used for the detection of erythrocyte subpopulations (Bayliss 
et al, 1991; Blanchard et al, 1995). The flow cytometer 
analyses large numbers of cells within a short time. 
Therefore it is especially useful for 
populations. For more objective and reproducible results we 
investigated the use of FC analysis for the quantification of 
erythrocyte subpopulations, Blanchard et al (1995) have 
described a method for this purpose using blood group 
antigens A, B and H as population markers.
We present a method suitable for a wide range of blood 
group antigens as erythrocyte population markers. Results 
are shown for the markers A, B, D, E, c, K and Fya. Using 
human antibodies (mostly crude sera) in a simple two-step 
procedure with FITC-conjugated Fai„ our method is much 
easier than the one described by Blanchard et al (1995)
Correspondence: E. C. M. Hendriks, Blood Transfusion Service, 
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which requires an extensive preparation of monoclonal, 
FITC-conjugated antibodies. Furthermore, fixation of the 
erythrocytes is rendered unnecessary by the use of IgG 
antibodies in combination with anti-human
MATERIALS AND METHODS
Antisera. Crude human sera containing IgG antibodies 
anti-E, -c, -K and -Fytt were obtained from the Central 
Laboratory of the Netherlands Red Cross Blood Transfusion
* Amsterdam. Anti-K was diluted 1:8
same
© 1997 Blackwell Science Ltd
phosphate-buffered saline containing 0*1% w/w bovine 
serum albumin (Sigma, St Louis, U.S.A.) (PBS-BSA). 
other sera were used undiluted. Anti-1) recommended for the 
bromelin test, was obtained 
used in a 1:16 dilution.
The IgG fractions of anti-A and anti-B were purified from 
high titre sera of patients on a Protein G Sepharose 4 last 
flow (Pharmacia) affinity column according to the recom­
mendations of the manufacturer. The concentrates were 
used at a dilution of 1:12 and 1:4 respectively.
Erythrocytes. Erythrocyte subpopulations were quantified 
in artificial mixtures of antigen positive and negative red 
blood cells (RBC) as well as in blood samples of patients after 
BMT. The subpopulations were distinguished using the blood 
group antigens A, B, D, E, c, K or Fy‘\  Blood of healthy 
volunteers was used for the artificial mixtures. The positive 
RBC were chosen to be heterozygous for the marker antigen
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(except antigen A and B). The phenotype R^r was used for 
D-antigen positive cells.
Fresh and stored blood samples of patients were analysed. 
Patients with leukaemia were transplanted with T-cell- 
depleted bone marrow as described by Schattenberg et al 
(1990). Blood was drawn before and several times after BMT.
Before labelling, most of the leucocytes were removed by 
centrifugation over Ficoll-Paque (Pharmacia, Uppsala, 
Sweden). For this purpose, one volume of blood was mixed 
with one volume of PBS-BSA. This mixture was centrifuged 
over 2 ml Ficoll-Paque (1-077 g/ml), and the RBC pellet was 
washed three times.
Most of the leucocytes were removed before sample 
storage. The erythrocytes were resuspended in 30% glycerol 
with 159 m M  sorbitol and 108 h im  NaCl and kept frozen in 
liquid nitrogen. After thawing, the samples were cleared of 
lysed cells by washing and centrifugation over Ficoll-Paque 
before labelling.
Labelling of erythrocytes. RBC were labelled with human 
IgG antibodies directed against the corresponding antigen by 
adding 50 ¿il of the suitable antiserum to 200 /¿I of an RBC 
suspension with a concentration of 1’25 x 10s cells/ml. 
After 1 h incubation at 3 7°C, the RBC were washed three 
times with 4 ml PBS-BSA. In round-bottommed 96-well 
microtitre plates 7 x 10s cells were pelleted, resuspended in 
70 /A 1:128 diluted FITC-conjugated anti-human IgG-Fab
(Cappel, Durham, U.S.A.), and incubated at room tempera­
ture for 30min. After washing three times with 200 /¿I PBS- 
BSA, the cells were resuspended in 1ml PBS-BSA and 
analysed with the flow cytometer.
Red cells were briefly fixed prior to labelling with anti-A. 
This was achieved by incubation with glutaraldehyde (0-1% 
in PBS) for 10 min.
Flow cytometry. Analysis was performed on a Epics-XL flow 
cytometer (Coulter Electronics) equipped with a 15mW 
argon laser and standard filter setting. Fluorescent signals 
were logarithmically amplified. Data were handled with Elite 
Software (Coulter Electronics). RBC were identified and 
selected according to their forward and side scatter profiles, 
For samples with low percentage positive cells, the positive 
region is set with the analysis of a 1% positive artificial 
mixture of the corresponding antigen.
Depending on the percentage cells found to be positive for 
the marker antigen, the following number of cells were 
analysed: 25 000 (<5% positive cells) or 10000 cells (>5%) 
at a flow rate of 250-350  cells/s.
RESULTS
Artificial mixtures
Mixtures of antigen positive and negative RBC were prepared 
at different concentrations and analysed by the new
m
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Fig 1. Fluorescence intensity histograms of artificial mixtures of 10% antigen-positive and 90% antigen-negative erythrocytes. A-positive cells 
had the Ar phenotype; D-positive RBC had the Rjr phenotype, E-, c-, K- and Fya-positive RBC used were heterozygous for the antigen.
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Table I. Comparison of determined percentages of antigen-positive cells to expected percentages in
RBC
RBC
heterozygous for the antigen.
Expected
percentage
Determined percentage
D E c K Fya A B
0 0-05 0-11 0-12 0-14 0-09 0*10 0'05
0-1 0-12 0-16 0-12 0-21 0*13 0-17 0’14
0*3 0-37 0-41 0-42 0-44 0*29 0-33 0-26
1-0 0-97 0-96 1-1 0-96 1-2 0*92 0-73
3-0 3-1 2-8 3-1 2-9 2-9 2-6 1-74
10 9-4 8-5 10 9-0 9-5 8-5 7-84
30 29 28 29 25 28 26 30
75 n.d. 70 75 76 n.d. 65 74
100 100 100 100 100 98 n.d. 99
n.d. =  not determined.
technique. The fluorescence intensity of the positive cells 
depended on the antigen but was always clearly distinct from 
that of the negative cells (Fig 1).
Agglutination occurred during centrifugation after sensi­
tization with anti-A antibodies. This resulted in an incorrect 
analysis. The problem was solved by the introduction of a 
brief fixation stage prior to labelling with anti-A.
The blank of the method was 0-09 ± 0-03%. Unlike the 
0*1% positive mixtures (mean 0-15%), the 0-3% positive 
mixtures (mean 0*36%) were clearly distinct from the blank 
(Table I). The determined percentages of positive RBC were in
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Fig 2. Correlation of the percentages of antigen-positive erythrocytes 
in blood samples of patients after BMT obtained by the presented 
method and by microsphere method. Antigens used for labelling were 
I), K, c, K and Fy“. Line of correlation found is y =  1 •03a: — 0-02, 
with a correlation coefficient of 0-96 {n — 54).
good agreement with the expected percentages of the 
artificial mixtures.
The reproducibility was determined by replicate analysis of 
artificial mixtures of 1% and 10% D-positive mixtures. The 
intra-assay results were 1-08 ±0-08 (SD)% (n =  10) and 
9-4 ± 0-2 (SD)% (n =  10) with coefficients of variation of 
7-2% and 2-2% respectively. The inter-assay results were
1-03 ± 0-10 (SD)% (n =  10) and 9-2 ± 0-6 (SD)% (n 6)
with coefficients of variation of 9-5% and 6-0% respectively.
Patient samples
The sensitivity of the method was tested by assaying 14 
samples drawn from patients just before BMT. All stated 
antigens except B were used as markers. The percentage false 
positive cells in these samples ranged from 0-04% to 0-25% 
with a mean of 0-12 ± 0-06 (SD)%. The detection limit 
deduced from this result was 0-31% (mean+3 SD).
A total of 54 positive blood samples of nine patients after 
BMT were analysed by the new technique as well as with the 
microsphere method described by de Man et al (1988). The 
correlation between both methods, shown in Fig 2, was
excellent (r 0*9 6).
The new flow cytometric method was used to monitor 
the percentage of donor and autologous erythrocytes after 
allogeneic BMT in patient blood samples. The data of 
eight representative patients with a successful BMT are 
shown in Fig 3. We monitored the donor erythrocytes of 
live patients and the autologous erythrocytes of four 
patients. In one patient both the donor erythrocytes 
(antigen K) and autologous erythrocytes (antigen D) were 
followed.
Regarding donor erythrocytes, there always was a clear 
increase in the percentages at 14 d after BMT compared to 
the percentages on the day of transplantation. In those cases
where the
ages declined
BMT. This is concordant with a successful destruction of
were followed, 
up to
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Fig 3. Percentages of donor ( ) and
autologous ( ) erythrocytes determined in
blood samples of patients at various time 
intervals after BMT, Antigens used as markers 
were D (+ and □ ), E (O), c (O and x), I< (☆, V 
and 5(c) and Fya (A). In one patient, the donor 
(%) as well as the autologous (□) erythrocytes 
were followed. Values in the shaded area are 
below the detection limit of ()• 31 %.
the autologous bone marrow and a 120 d survival of 
erythrocytes in peripheral blood.
DISCUSSION
The new flow cytometric method used blood group antigens 
A, B, D, E, c, K and Fya to quantify erythrocyte subpopu­
lations. The antigen of choice was indirectly labelled with 
FITC. We chose indirect labelling to avoid the conjugation of 
the antibodies with FITC. Another advantage of indirect 
labelling was the amplification of the signal (Garratty & 
Arndt. 1995).
To avoid agglutination occurring in the second step of the 
labelling procedure, we used Fab of anti-human IgG instead 
of the whole molecule. We preferred this strategy over the 
time-consuming overnight fixation described by Blanchard et 
al (1995). Agglutination occurred after the first labelling 
step with anti-A antibodies, although only IgG antibodies 
were used. This agglutination was prevented by a mild and 
brief (lOmin) fixation with glutaraldehyde.
Fluorescence intensity of the positive RBC differed among 
the antigens used as marker. This was mainly caused by 
differences of antigen density between blood group antigens. 
The affinity for the antigen and the concentration of the 
antibodies also played a role. The detection limit of 031% 
was deduced from the results with patient blood samples 
drawn just before BMT (f =  Od). This result was confirmed 
by the percentages of autologous erythrocytes found in 
samples drawn 120d after BMT or later. All these values 
were below the detection limit. The mean of the negative 
patient samples (0'12 ± 0*06%) was higher than the blanks 
with blood of healthy volunteers (mean 0-09 ± 0-03%). This 
effect was probably caused by the medication and/or the 
disease of the patients.
Most of the described flow cytometric methods for analysis 
of erythrocyte subpopulations are used to determine the
extent of feto-maternal haemorrhage (FMH) and use solely 
antigen D as marker (Nance et al, 1989; Patton et al, 1990; 
Bayliss et al, 1991). Sensitivities of 0-l-0-2%  have been 
achieved. Blanchard et al (19 9 5) developed a flow cytometric 
method to detect erythrocyte subpopulations after BMT. 
They label antigen A, B and H directly with FITC, thereby 
reaching a sensitivity level of 1%.
Our method is simple, accurate and sensitive. A series of 
10 samples can be processed within 5 h. Furthermore, little 
time is needed for the preparation of the reagents. The 
method has been shown to be appropriate for the routine 
follow-up of patients after BMT with each of the presented 
seven markers. All live examples following donor erythro-
had a detectable in the
samples drawn 1.4 d after BMT. The earliest detection of 
donor erythrocytes that Blanchard et al (199 5) report is 24 d 
after BMT. It is unclear whether or not they evaluated 
samples drawn 14 d after BMT.
A precondition for application of this How cytometric 
method, which is based on blood group differences, is the 
transfusion policy that only RBC negative lor the marker 
antigens are transfused. This policy must be applied at least 
120 d before sampling.
To be able to investigate more patients, the number of 
suitable marker antigens has to be extended (C, Fy1’. Jk11, Jk1’, 
M, N, S and s). With the expanded set of marker antigens, 
almost all patients after BMT can be monitored, 
potential applications of the presented method are detection 
of FMH, survival studies of transfused erythrocytes, and 
studies of natural occurring erythrocyte chimaerism and
*  «mosaicism.
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